Enlaza Therapeutics · 3 weeks ago
Scientist II, Analytical Development (Biologics Discovery/CMC)
Enlaza Therapeutics is a biotech company developing an innovative synthetic biology platform to create a disruptive new class of biologic therapeutics. The company is seeking a highly motivated analytical development scientist to support the characterization and development of protein- and antibody-based therapeutics, focusing on method development, optimization, and execution for pre-clinical research and early-stage manufacturing.
BiopharmaBiotechnologyHealth CareTherapeutics
Responsibilities
Independently design, develop, and optimize analytical methods for release, stability, and characterization of biologics, such as antibodies, ADCs, and bispecifics
Perform routine physicochemical analytical testing to support biologics drug discovery research and early-stage process development, including HPLC (SEC, HIC, IEX), CE (icIEF, CE-SDS), physical testing (UV-Vis, pH, osmolality), and impurities (HCP)
Analyze and interpret complex analytical data, identifying trends and correlations to inform project decisions and support process development
Maintain detailed and accurate records in electronic laboratory notebooks, and author and review technical documents including protocols, reports, and method procedures
Propose continuous improvement in analytical sciences in alignment with industry advances and trends
Represent the analytical development function in cross-functional CMC and research project teams
Contribute to oversight of external analytical development activities, including method development, analytical life cycle management, and stability programs
Qualification
Required
Advanced degree in analytical chemistry, biochemistry, or closely related field, with 3+ years of industry experience in analytical development for protein-based biopharmaceutical products (equivalent combined education and experience will be considered for the role)
Subject-matter expertise in analytical separation sciences and proven track record of successful method development and validation
Demonstrated skill in hands-on operation of modern analytical instruments
Strong understanding of protein chemistry and degradation pathways
Comfort operating on a small, dynamic team and open to providing and receiving cross-training opportunities
Excellent written communication skills
Previous exposure or participation in authoring regulatory submission content
Understanding of early-stage biopharmaceutical development manufacturing unit operations, manufacturing science and technology, and GxP quality control
Preferred
Previous experience with analytical support of process development, formulation, or drug product groups
Benefits
401(k)
Dental insurance
Employee assistance program
Flexible schedule
Flexible spending account
Health insurance
Life insurance
Paid time off
Parental leave
Relocation assistance
Retirement plan
Vision insurance
Year-end shutdown
Company
Enlaza Therapeutics
Enlaza Therapeutics is a biotechnology research company.
Funding
Current Stage
Growth StageTotal Funding
$180.02MKey Investors
J.P. Morgan Asset ManagementAvalon Ventures
2025-09-10Series Unknown· $15M
2024-04-30Series A· $100M
2022-10-12Seed· $61M
Recent News
2025-12-18
Labiotech UG
2025-10-09
Company data provided by crunchbase